Yongan Zhou

No. 169 Changle West Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Immune-related adverse events in patients with preexisting myasthenia gravis and thymoma following immune checkpoint inhibitor treatment: a retrospective, observational study.

Immune-related adverse events in patients with preexisting myasthenia gravis and thymoma following immune checkpoint inhibitor treatment: a retrospective, observational study.

Journal: Frontiers in immunology

Published: May 25, 2025

Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma.

Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma.

Journal: Thoracic cancer

Published: April 21, 2025

Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study.

Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study.

Journal: International journal of surgery (London, England)

Published: January 29, 2024

Comparative study of the clinical efficacy of subcostal thoracoscopy and median sternotomy in treating thymoma: a propensity score-matching analysis.

Comparative study of the clinical efficacy of subcostal thoracoscopy and median sternotomy in treating thymoma: a propensity score-matching analysis.

Journal: The Journal of international medical research

Published: January 09, 2024

Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non-Small Cell Lung Cancer: The TD-FOREKNOW Randomized Clinical Trial.

Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non-Small Cell Lung Cancer: The TD-FOREKNOW Randomized Clinical Trial.

Journal: JAMA oncology

Published: August 03, 2023

Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma.

Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma.

Journal: Genome medicine

Published: June 16, 2023

CircGFPT1 regulates the growth and apoptosis of esophageal squamous cell carcinoma through miR-142-5p/HAX1 axis.

CircGFPT1 regulates the growth and apoptosis of esophageal squamous cell carcinoma through miR-142-5p/HAX1 axis.

Journal: General thoracic and cardiovascular surgery

Published: December 22, 2022

Nomogram for predicting the risk of postoperative myasthenic crisis in patients with thymectomy.

Nomogram for predicting the risk of postoperative myasthenic crisis in patients with thymectomy.

Journal: Annals of clinical and translational neurology

Published: November 27, 2022

Subtype-based analysis of cell-in-cell structures in non-small cell lung cancer.

Subtype-based analysis of cell-in-cell structures in non-small cell lung cancer.

Journal: American journal of cancer research

Published: November 11, 2022

Clinical Comparative Analyses of Thymectomy Between Subxiphoid and Subcostal Arch Thoracoscopic Resection and Median Sternotomy for the Treatment of Thymoma With Myasthenia Gravis in Chinese Patients.

Clinical Comparative Analyses of Thymectomy Between Subxiphoid and Subcostal Arch Thoracoscopic Resection and Median Sternotomy for the Treatment of Thymoma With Myasthenia Gravis in Chinese Patients.

Journal: The Journal of surgical research

Published: May 09, 2022

Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE).

Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE).

Journal: International journal of surgery (London, England)

Published: January 25, 2022

Correction to: Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: a Multicenter Retrospective Cohort Study.

Correction to: Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: a Multicenter Retrospective Cohort Study.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: November 09, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026